.
BIOCON financial statements
* Numbers in millions
| Capitalization * | 394 068 |
|---|---|
| EV * | 485 979 |
| Number of shares * | 1 187 |
| EPS | 6,24 |
| Revenue * | 69 701 |
| Net income * | 7 405 |
| Operating profit * | 6 047 |
| Total liabilities * | 100 147 |
| Net debt * | 35 285 |
| Total assets * | 185 223 |
| Equity * | 76 269 |
| Cash and investments * | 26 383 |
.
BIOCON valuation
| P/E | 53,22 |
|---|---|
| P/B | 5,17 |
| P/S | 5,65 |
| E/P | 2 |
| P/FCF | -67,18 |
.
BIOCON profitability
| ROE | 10% |
|---|---|
| ROA% | 4% |
| ROIC% | 4% |